AU2007269233B2 - Method of producing Factor VIII proteins by recombinant methods - Google Patents

Method of producing Factor VIII proteins by recombinant methods Download PDF

Info

Publication number
AU2007269233B2
AU2007269233B2 AU2007269233A AU2007269233A AU2007269233B2 AU 2007269233 B2 AU2007269233 B2 AU 2007269233B2 AU 2007269233 A AU2007269233 A AU 2007269233A AU 2007269233 A AU2007269233 A AU 2007269233A AU 2007269233 B2 AU2007269233 B2 AU 2007269233B2
Authority
AU
Australia
Prior art keywords
fviii
protein
nucleic acid
domain
factor viii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007269233A
Other languages
English (en)
Other versions
AU2007269233A1 (en
Inventor
William Drohan
Michael Griffith
Randal J. Kaufman
Steven W. Pipe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CNJ Holdings Inc
University of Michigan (System)
Original Assignee
CNJ Holdings Inc
University of Michigan (System)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CNJ Holdings Inc, University of Michigan (System) filed Critical CNJ Holdings Inc
Publication of AU2007269233A1 publication Critical patent/AU2007269233A1/en
Assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INSPIRATION BIOPHARMACEUTICALS, INC. reassignment THE REGENTS OF THE UNIVERSITY OF MICHIGAN Alteration of Name(s) of Applicant(s) under S113 Assignors: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Application granted granted Critical
Publication of AU2007269233B2 publication Critical patent/AU2007269233B2/en
Assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN, CNJ HOLDINGS, INC. reassignment THE REGENTS OF THE UNIVERSITY OF MICHIGAN Request for Assignment Assignors: INSPIRATION BIOPHARMACEUTICALS, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2007269233A 2006-06-30 2007-06-29 Method of producing Factor VIII proteins by recombinant methods Ceased AU2007269233B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81817706P 2006-06-30 2006-06-30
US60/818,177 2006-06-30
PCT/US2007/072506 WO2008005847A2 (en) 2006-06-30 2007-06-29 Method of producing factor viii proteins by recombinant methods

Publications (2)

Publication Number Publication Date
AU2007269233A1 AU2007269233A1 (en) 2008-01-10
AU2007269233B2 true AU2007269233B2 (en) 2011-06-09

Family

ID=38895363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007269233A Ceased AU2007269233B2 (en) 2006-06-30 2007-06-29 Method of producing Factor VIII proteins by recombinant methods

Country Status (6)

Country Link
US (2) US20080070251A1 (enExample)
EP (2) EP2035572A4 (enExample)
JP (2) JP2009542225A (enExample)
AU (1) AU2007269233B2 (enExample)
CA (1) CA2656558A1 (enExample)
WO (1) WO2008005847A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090203077A1 (en) * 2006-06-30 2009-08-13 The Regents Of The University Of Michigan Method of producing factor viii proteins by recombinant methods
US20120028900A1 (en) * 2006-06-30 2012-02-02 Kaufman Randal J Method of producing factor viii proteins by recombinant methods
CA2837995A1 (en) * 2011-06-03 2012-12-13 The Regents Of The University Of Michigan Method of producing factor viii proteins by recombinant methods
CN103917554B (zh) 2011-10-18 2017-03-08 杰特有限公司 用于改善重构后纯化的因子viii的稳定性的方法
US20150045303A1 (en) * 2012-04-24 2015-02-12 Novo Nordisk A/S Pharmaceutical Composition Suitable for Treatment of Haemophilia
EP3770263A1 (en) * 2013-03-12 2021-01-27 AGC Biologics, Inc. Improved recombinant protein expression using a hybrid chef1 promoter
WO2014152530A1 (en) * 2013-03-15 2014-09-25 Bayer Healthcare Llc Variant factor viii polypeptides and methods of their production and use
WO2015091130A1 (en) * 2013-12-20 2015-06-25 F. Hoffmann-La Roche Ag Method for improving the recombinant production of soluble fusion polypeptides
EP3083977B1 (en) 2013-12-20 2018-02-28 F. Hoffmann-La Roche AG Improved recombinant polypeptide production methods
EP3114138B1 (en) 2014-03-05 2021-11-17 Pfizer Inc. Improved muteins of clotting factor viii
CA2942770A1 (en) * 2014-03-23 2015-10-01 Advantech Bioscience Farmaceutica Ltda. Enhancement of recombinant protein expression with copper
US9907835B2 (en) 2014-04-01 2018-03-06 Advanced Bioscience Farmacêutica LTDA Stable Factor VIII formulations with low sugar-glycine
CN106456720A (zh) 2014-04-01 2017-02-22 爱德技术生物科学有限公司 在无钙作为赋形剂下因子viii的稳定性
KR102554850B1 (ko) * 2015-02-06 2023-07-13 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도
AU2016282334B2 (en) 2015-06-24 2022-07-21 F. Hoffmann-La Roche Ag Anti-transferrin receptor antibodies with tailored affinity
MX2018003822A (es) 2015-10-02 2018-06-22 Hoffmann La Roche Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso.
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
KR102219859B1 (ko) * 2016-06-24 2021-02-25 재단법인 목암생명과학연구소 재조합 단쇄 fviii 및 그 화학 접합물
CA3191743A1 (en) * 2020-09-16 2022-03-24 Generation Bio Co. Non-viral dna vectors and uses thereof for expressing fviii therapeutics
JP2025538565A (ja) 2022-11-23 2025-11-28 エフ． ホフマン－ラ ロシュ アーゲー 組換えタンパク質発現を増加させるための方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040147436A1 (en) * 2003-01-28 2004-07-29 Hun-Taek Kim Factor VIII polypeptide
US20060014683A1 (en) * 1996-04-24 2006-01-19 University Of Michigan Inactivation resistant factor VIII

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4599308A (en) 1981-10-06 1986-07-08 Hamer Dean H Protein from SV40 recombinants
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5214033A (en) * 1983-03-31 1993-05-25 Scripps Clinic & Research Foundation Factor VIII coagulant polypeptides
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US4879236A (en) 1984-05-16 1989-11-07 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4745057A (en) 1984-05-18 1988-05-17 Eli Lilly And Company Method, vectors and transformants for high expression of heterologous polypeptides in yeast
US4577729A (en) * 1984-12-05 1986-03-25 Westinghouse Electric Corp. Guide rail clamping assembly
US4912038A (en) 1984-12-11 1990-03-27 California Biotechnology Inc. Recombinant DNA sequence encoding alveolar surfactant protein
US4879224A (en) 1985-01-10 1989-11-07 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
US4761371A (en) 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
MX9203440A (es) * 1985-04-12 1992-07-01 Genetics Inst Proteinas procoagulantes novedosas.
ATE87663T1 (de) 1986-01-03 1993-04-15 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ- proteinen.
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
AT388079B (de) 1986-04-18 1989-04-25 Helmut Ing Koenig Backofen
US5451521A (en) 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
US5422260A (en) * 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4877729A (en) 1986-07-14 1989-10-31 Genetics Institute, Inc. Recombinant DNA encoding novel family of primate hematopoietic growth factors
US4912040A (en) 1986-11-14 1990-03-27 Genetics Institute, Inc. Eucaryotic expression system
CA1331157C (en) 1987-04-06 1994-08-02 Randal J. Kaufman Method for producing factor viii:c-type proteins
US5004803A (en) 1988-11-14 1991-04-02 Genetics Institute, Inc. Production of procoagulant proteins
US5661008A (en) * 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
US5563045A (en) * 1992-11-13 1996-10-08 Genetics Institute, Inc. Chimeric procoagulant proteins
US20040092442A1 (en) * 1996-04-24 2004-05-13 University Of Michigan Inactivation resistant factor VIII
US5838437A (en) * 1997-04-09 1998-11-17 Micron Optics, Inc. Reference system for optical devices including optical scanners and spectrum analyzers
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
ATE222925T1 (de) * 1998-03-12 2002-09-15 Inst Genetics Llc Verbessertes verfahren zur herstellung von faktor viii
CA2703948A1 (en) * 2007-11-01 2009-05-07 University Of Rochester Recombinant factor viii having increased stability

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060014683A1 (en) * 1996-04-24 2006-01-19 University Of Michigan Inactivation resistant factor VIII
US20040147436A1 (en) * 2003-01-28 2004-07-29 Hun-Taek Kim Factor VIII polypeptide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MIAO HONGZHI Z ET AL: "Bioengineering of coagulation factor VIII for improved secretion", Blood, vol. 103, no. 9, 2004, pages 3412-3419. *

Also Published As

Publication number Publication date
US20110039302A1 (en) 2011-02-17
WO2008005847A2 (en) 2008-01-10
EP2035572A2 (en) 2009-03-18
AU2007269233A1 (en) 2008-01-10
JP2009542225A (ja) 2009-12-03
WO2008005847A3 (en) 2008-10-16
EP2035572A4 (en) 2010-01-06
EP2520586A1 (en) 2012-11-07
CA2656558A1 (en) 2008-01-10
JP2014000080A (ja) 2014-01-09
US20080070251A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
EP2520586A1 (en) Method of producing factor VIII proteins by recombinant methods
EP0910628B1 (en) Inactivation resistant factor viii
WO2012170289A1 (en) Method of producing factor viii proteins by recombinant methods
US20140357565A1 (en) Method of producing factor viii proteins by recombinant methods
KR101507718B1 (ko) 연장된 생체내 반감기를 갖는 인자 ｖｉｉｉ, 폰 빌레브란트 인자 또는 이들의 복합체
US20130072434A1 (en) Inactivation resistant factor viii
US20040092442A1 (en) Inactivation resistant factor VIII
WO1997040145A9 (en) Inactivation resistant factor viii
KR20090102795A (ko) 연장된 생체내 반감기를 갖는 변형된 응고 인자
CA2451584A1 (en) Modified cdna factor viii and its derivatives
JP6676551B2 (ja) 改変フォンウィルブランド因子
JP2016518378A (ja) 複合体
JP2008537680A (ja) 安定性の増大された改変型凝固第ｖｉｉｉ因子およびその誘導体
JP2005511038A (ja) 第ｖｉｉｉ因子ｃ２ドメインのバリアント
US20090203077A1 (en) Method of producing factor viii proteins by recombinant methods
US20030148953A1 (en) Inactivation resistant factor VIII
EP1502921A1 (en) Recombinant mutated human factor VIII (FVIII) with improved stability
HK1178545A (en) Method of producing factor viii proteins by recombinant methods

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE CO-INVENTOR NAME FROM GRIFFITH, WILLIAM TO GRIFFITH, MICHAEL

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: THE REGENTS OF THE UNIVERSITY OF MICHIGAN; CNJ HOL

Free format text: FORMER OWNER WAS: THE REGENTS OF THE UNIVERSITY OF MICHIGAN; INSPIRATION BIOPHARMACEUTICALS, INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired